] i transient that was associated with increased tissue levels of nNOS protein and cGMP concentration compared with gene transfer of Ad.PRSx8-Cherry alone. nNOS inhibition significantly increased [Ca 2+ ] i after Ad.PRSx8-nNOS/Cherry expression. We conclude that artificial upregulation of stellate sympathetic nNOS via targeted gene transfer can directly attenuate intracellular Ca 2+ and may provide a novel method for decreasing enhanced cardiac sympathetic neurotransmission. 
N itric oxide (NO) synthesis catalyzed by neuronal NO synthase (nNOS) acts as a biological messenger involved in events crucial to neuronal cell function, such as neurotransmitter release and gene transcription. 1 Emerging evidence shows that disruption of the NO-cGMP pathway enhances sympathetic function at several sites in the cardiac-neural axis. [2] [3] [4] [5] Hypertension causes enhanced neurohumoral activation [6] [7] [8] and abnormal calcium signaling in cardiac sympathetic neurons, 9 including the pacemaker cells they innervate. 10 The mechanisms responsible for this sympathetic phenotype still remain elusive. One candidate is oxidative stress that is reported to disrupt NO-soluble guanylate cyclase (sGC)-cGMP-dependent pathways that couple to the regulation of intracellular calcium. 10, 11 This pathway appears to play an important role in determining cardiac noradrenergic activity both pre-and postjunctionly at the end organ level during the development of hypertension. 7, 10 Gene transfer using adenoviral vectors constructed with a noradrenergic neuron-specific promoter (PRS×8) to drive nNOS (Ad.PRSx8-nNOS) is highly effective in modifying gene expression 12 and decreasing intracellular Ca 2+ concentration [Ca 2+ ] i in cardiac sympathetic postganglionic neurons from normotensive rats. 13 Moreover, it also decreases cardiac sympathetic transmission in adult normotensive 12 and spontaneously hypertensive rats (SHRs). 7 Therefore, we hypothesized that the recently reported 9 impaired calcium handling in postganglionic stellate sympathetic neurons in young (prehypertensive) SHRs was a consequence of impaired NO-cGMP signaling that occurs as an early cellular marker linked to disruption of Ca 2+ regulated exocytosis. We further hypothesized that transduction of SHR stellate sympathetic neurons with targeted gene transfer with nNOS marked by mCherry could restore normal NO-cGMP signaling and rescue abnormal calcium handling.
Abstract-Hypertension is associated with the early onset of cardiac sympathetic hyperresponsiveness and enhanced intracellular Ca 2+ concentration [Ca 2+ ] i in sympathetic neurons from both prehypertensive and hypertensive, spontaneously hypertensive rats (SHRs). Oxidative stress is a hallmark of hypertension, therefore, we tested the hypothesis that the inhibitory action of the nitric oxide-cGMP pathway on [Ca 2+ ] i transients is impaired in cardiac sympathetic neurons from the SHR. Stellate ganglia were isolated from young prehypertensive SHRs and age-matched normotensive Wistar-Kyoto rats. [Ca 2+ ] i was measured by ratiometric fluorescence imaging. Neurons from the prehypertensive SHR ganglia had a significantly higher depolarization evoked [Ca 2+ ] i transient that was also associated with decreased expression of neuronal nitric oxide synthase (nNOS), β1 subunit of soluble guanylate cyclase and cGMP when compared with the Wistar-Kyoto rat ganglia. Soluble guanylate cyclase inhibition or nNOS inhibition increased [Ca 2+ ] i in the Wistar-Kyoto rats but had no effect in SHR neurons. A nitric oxide donor decreased [Ca 2+ ] i in both sets of neurons, although this was markedly less in the SHR. A novel noradrenergic cell specific vector (Ad.PRSx8-nNOS/Cherry) or its control vector (Ad.PRSx8-Cherry) was expressed in sympathetic neurons. In the SHR, Ad.PRSx8-nNOS/Cherry-treated neurons had a significantly reduced peak [Ca Figure 1A and 1C). However, the α1 subunit of sGC protein was not different between the 2 strains ( Figure 1B ). cGMP concentration in stellate ganglia was significantly lower in the young SHRs compared with the WKY rats ( Figure 1D ).
Intracellular Free Calcium Transients in Cardiac Sympathetic Neurons
Intracellular calcium concentration was measured by ratiometric imaging of Fura-4F in single cardiac sympathetic neurons. Two to 4 separate cultures were used in each experiment. Each coverslip was only imaged once because of different pharmacological interventions. A typical calcium transient response to 100 mmol/L of KCl is shown in Figure  2A . Baseline Figure 2B ).
Pharmacological Manipulation of NO-cGMP Pathway
To determine whether the NO-cGMP pathway was impaired in the SHR, the exogenous NO donor SIN-1 (10 μmol/L), guanylyl cyclase inhibitor 1H-(1,2,4)-oxadiazolo-(4,3-a)-quinoxalin-1-one (10 μmol/L), and the nNOS-specific inhibitor
10 µmol/L) were introduced separately at 6 minutes from the start of the experiment after the first high K + stimulation (S1; Figure 3A ). After 10 minutes of incubation, neurons were stimulated again (S2 at 16 minutes) in the presence of drugs. In the control experiments, no significant changes were observed between S1 and S2 ( Figure S2) Figure 3B ), although this was markedly less in the SHRs (10.89±3.88%, P<0.05; Figure 3C Figure 3C ). Taken together, these results show there is a significant molecular and cellular impairment in prehypertensive SHR stellate sympathetic neurons involving the nNOS-sGC-cGMP pathway linked to [Ca 2+ ] i signaling.
Effect of nNOS Gene Transfer
Western Blotting and cGMP Production Western blotting in SHRs showed increased nNOS expression in Ad.PRSx8-nNOS/Cherry-transduced stellate ganglia compared with those transduced with Ad.PRSx8-Cherry ( Figure 4A ). nNOS expression in nNOS virus-transduced SHR stellate ganglia was not different compared with the WKY ( Figure  S3A ). The α1 and β1 subunits of sGC proteins were not affected by overexpression of nNOS ( Figure 4B and 4C) . However, cGMP concentration from infected SHR stellate ganglia was significantly increased in the transduced with Ad.PRSx8-nNOS/ Cherry when compared with the transduced with Ad.PRSx8-Cherry ( Figure 4D ). α1-sGC/ β-actin (a.u) , and significant reduction in β 1 -sGC (C). Western blot band optical density was normalized to that of β-actin as a loading control. D, Tissue levels of cGMP in the stellate ganglia from the young SHRs were significantly lower than that measured in the WKY rats. *P<0.05, **P<0.01, unpaired t test.
Intracellular Free Calcium Transients in Cardiac Sympathetic Neurons
Fluorescence microscopy detected mCherry expression in stellate sympathetic neurons after transduction with Ad.PRSx8-Cherry ( Figure 5A ) or Ad.PRSx8-nNOS/Cherry ( Figure 5B ). However, not all neurons expressed mCherry ( Figure 5Aii and 6A ] i transient was significantly decreased in mCherry-expressing neurons when compared with the nonexpressing neurons in both strains (Table  S1 , available in the online-only Data Supplement). This indicates the importance of having an independent fluorescent marker to confirm a transgene expression. We did not systematically look across the whole coverslip quantitatively, but we estimated that our transduction efficiency was ≈60% to 70%. We only chose the mCherry-expressing neurons to measure the calcium transient for subsequent comparison between WKY and SHR cells. α1-sGC /β-actin (a.u) 
NO-cGMP Signaling in the Cardiac Sympathetic Ganglia of the SHR
Abundant evidence supports the concept of sympathetic hyperactivity and parasympathetic insufficiency as a significant component in the pathogenesis of not only early and borderline hypertension, but also in the maintenance of sustained essential hypertension. [14] [15] [16] Moreover, defective NO synthase signaling via nNOS leads to increased norepinephrine release from the right atria in response to field stimulation in the adult SHR. 7 We now show that this defect is also present in young prehypertensive SHRs where nNOS, β1-sGC, and cGMP were all reduced in the stellate ganglia. There is, however, no evidence to suggest that levels of l-arginine, biopterin, or tetrahydrobiopterin in intracardiac ganglia/myocytes are different between the SHRs and WKY rats, 10 suggesting that NO synthesis is not rate limited by substrate or cofactor availability.
Intracellular free calcium plays a critical role in the pathophysiology of essential hypertension. Abnormal calcium handling properties have been observed in SHR vascular smooth muscle cells, 17 endothelial cells, 18 and recently in sympathetic neurons, 9 thus providing a molecular link to enhanced noradrenergic neurotransmission. In this study, normal NO-cGMP modulated [Ca 2+ ] i signaling was demonstrated in young WKY rats, with increased calcium transients after preincubation with nNOS or sGC inhibitors, and reduced transients with an NO donor. This indicates that the NO signaling system was intact in the WKY neurons. In contrast, experiments with cardiac sympathetic neurons from young SHR animals revealed abnormal NO-cGMP signaling, in which NO-cGMP inhibition failed to augment calcium signaling. Bypassing the enzymatically activated pathway with SIN-1 decreased high K + evoked [Ca 2+ ] i indicating that pathways downstream to NOS-sGC were still operating, albeit with a markedly reduced responsiveness compared with that seen in the WKY rat. This is in agreement with others who report the NO-cGMP regulatory cascade for Ca 2+ handling is suppressed in SHR cardiomyocytes 19 and endothelial cells. reverse the enhanced arterial chemoreceptor function seen in rabbits with heart failure, 22 increase cardiac parasympathetic function, 15, 23 and decrease β-adrenergic responsiveness of l-type calcium current in pacemaker cells from the SHR. 10 However, one of the challenges with viral vectors is to ensure a degree of cell-specific gene transfer to avoid establishing expression of the enzyme in cells that do not constitutively express it, thereby avoiding abnormal paracrine signaling of NO. In a previous study, we have shown that Ad.PRSx8-nNOS is highly specific and effective in modifying gene expression in sympathetic neurons. 12 However, because this construct had no fluorescence-expressing reporter in the vector, it was difficult to distinguish the transduced neurons overexpressing nNOS from those expressing endogenous nNOS.
In this work, we constructed an adenovirus with a noradrenergic specific promoter (PRS×8) driving expression of a red fluorescent protein mCherry coupled to NO synthase (Ad.PRSx8-nNOS/Cherry). The importance of tagging a reporter protein is underscored by the observation that not all cells were transduced by Ad.PRSx8-nNOS. Therefore, it is possible that a significant number of false-negatives might occur after gene transfer without the reporter protein when measuring the efficacy of nNOS on calcium transients. Gene transfer with Ad.PRSx8-nNOS/Cherry to stellate ganglia resulted in an ≈5-fold upregulation of nNOS protein expression compared with Ad.PRSx8-Cherry. However, this would be an underestimation if not all neurons were transduced uniformly as our data suggest. Although protein levels of α1-sGC or β1-sGC were not changed after nNOS transduction, enhanced cGMP concentration was observed, with NO synthase inhibition reversing the modulatory role of nNOS overexpression on whole cell calcium transients.
Perspectives
Impaired cardiac sympathetic function is a hallmark of the hypertensive phenotype. Here, we show that a part of this may be attributed to dysregulation of nNOS-NO-Ca 2+ signaling in sympathetic neurons that predominantly innervate the heart. The underlying mechanism for nNOS-derived NO modulating calcium handling in neurons is not completely understood. Microdomains of nNOS in neurons in subcellular compartments contribute to calcium homeostasis and have been found to regulate calcium handling in endoplasmic reticulum 24, 25 and mitochondria. 26 In addition, we recently reported that mitochondria plays a major role in the depolarization evoked [Ca 2+ ] i difference observed between the young SHRs and WKY rats by reducing the mitochondrial membrane potential in the SHR sympathetic neurons. 9 Some of the physiological and pathological effects of NO result from its actions at the mitochondrial level. NO/cGMP stimulates mitochondrial biogenesis, and this stimulation is associated with increased mitochondrial function. 27 Further research is needed to investigate whether overexpression of nNOS activates mitochondrial biogenesis in cardiac postganglionic sympathetic neurons. Although gene transfer with viral vectors is a future therapeutic aspiration, a number of less invasive interventions have proved promising. Feeding hypertensive rats with l-arginine supplements 28 or statins 29 promotes NO activity and decreases cardiac sympathetic responsiveness. Interestingly, l-arginine supplementation reduces tyrosine hydroxylase levels, 28 a key precursor for the production of norepinephrine, although we saw no change in this enzyme after nNOS gene transfer ( Figure S3B ).
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What Is New?
• We show that impaired signaling involving the NO-cGMP pathway in stellate sympathetic neurons is directly related to enhance intracellular calcium transients.
• Noradrenergic cell specific gene transfer with nNOS rescues the abnormal calcium phenotype in these neurons.
What Is Relevant?
• We provide a critical link among abnormal sympathetic neurotransmission, impaired free radical signaling, and enhanced intracellular calcium levels in animals predisposed to hypertension.
• Moreover, this dysregulated signaling in the peripheral nervous system is an early marker in the genesis of the hypertensive phenotype.
clones containing nNOS/Cherry transgene driven by PRSx8 promoter and adenoviral proteins were selected and propagated. Plasmid DNA from these clones was purified and transfected into HEK293 packaging cell line using Lipofectamine 2000 transfection reagent (Invitrogen, USA) for virus construction. Viral stock was amplified to preparative amount by subsequent passaging and purified by ion exchange chromatography (AdenoPure kit; PureSyn, USA). Viral titre was determined by immunocytochemistry using antibody against hexon viral envelop protein (Adeno-X Rapid Titer Kit; Clontech, USA). Ad-PRSx8-nNOS/Cherry titre was 2.8x10e10 iu/ml. Ad-PRSx8-mCherry adenovirus was constructed, propagated, purified and titred according to the same protocols; Ad-PRSx8-mCherry titre was 4.17x10e10 iu/ml. nNOS/Cherry and mCherry expression driven by PRSx8 promoter was verified by transducing PC12 rat neuronal cell line.
Adenovirus vector transduction
A novel noradrenergic cell specific adenoviral vector expressing nNOS fused in frame at Cterminal end to red fluorescent protein mCherry (Ad.PRSx8-nNOS/Cherry) was transferred to cultured cardiac sympathetic neurons. An adenoviral vector expressing only mCherry (Ad.PRSx8-Cherry) was used as a control for comparing the effect of viral transduction (supplement Figure S1 ). 2×10 9 pfu of adenoviral vector was used to infect neurons or ganglia in a 4 well plate (1.9 cm 2 /well, Nunc, Denmark). The virus containing medium was left in the well a maximum of 12 hours before changing to fresh medium. The experiments were performed after 3-4 days following gene transfer. [Ca 2+ ] i was determined in single neurons using Fura-4F acetoxymethyl ester (Fura-4F/AM) fluorescence ratio imaging. Subconfluent sympathetic neurons were loaded with 2.5 µmol/L Fura-4F/AM at 37 °C for 30 min. Loaded neurons were imaged with a CoolSnap digital CCD camera (Photometrics) connected to a PTI easy ratio pro fluorescence imaging system (Photon Technology International, Inc) housed on an inverted Nikon microscope equipped with a 60x, oil-immersion objective. The cover slip containing the neurons was placed into a temperaturecontrolled (37 °C), gravity fed, perfusion chamber (volume: 100 µl), perfused with Tyrode solution at a flow rate of 3 ml/min. The evoked [Ca 2+ ] i transient was evaluated by 30 s exposure to 100 mM KCl (with equimolar reduction in NaCl) in the Tyrode solution. Fura-4F/AM was excited alternately at 340 nm and 380 nm at intervals of 2500 ms, and the emitted fluorescence measured at 510 nm. Fluorescence excitation ratios were transformed into [Ca 2+ ] i concentrations using the equation derived by Grynkiewicz et al Western blot band optical density was normalised to that of β-actin as a loading control. No significant changes were observed between two groups. n=4 in each group.
Measurement of free intracellular calcium concentration

